Sign Out
Symptoms and signs: The maximum tolerated dose of talquetamab has not been determined. In clinical studies, doses of up to 1.2 mg/kg: once every 2 weeks and 1.6 mg/kg every month have been administered.
Treatment: In the event of an overdose, the patient should be monitored for any signs or symptoms of adverse effects and appropriate symptomatic treatment should be instituted immediately.
Continue with Google